Puma Biotechnology, Inc.
PBYI
$3.01
-$0.03-0.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 147.59% | 40.23% | 525.26% | 457.52% | 219.91% |
| Total Depreciation and Amortization | -1.00% | 0.04% | 4.41% | 8.37% | 12.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.42% | -34.26% | -50.65% | -43.35% | -38.42% |
| Change in Net Operating Assets | -850.20% | 40.57% | -11.73% | -38.26% | 86.40% |
| Cash from Operations | -12.15% | 44.09% | 39.32% | 7.97% | 159.73% |
| Capital Expenditure | 16.43% | 60.00% | 10.53% | -35.29% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 101.41% | -7.36% | -15.26% | 41.11% | -6.66% |
| Cash from Investing | 100.83% | -6.87% | -15.16% | 40.91% | -7.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -94.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -544.93% | -81.97% | -- |
| Cash from Financing | -- | -- | -1,026.16% | -576.53% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.35% | -294.90% | -491.59% | -8.40% | 558.69% |